Faculty

Print Friendly
DouglasReintgen

Douglas Reintgen, MD

Professor, College Of Medicine Surgery

College Of Medicine Surgery

Contact Info MDC 52
12901 Bruce B Downs Blvd.
Tampa, FL 33647

Academic Email: dreintge@health.usf.edu

Academic Phone: (813) 440-

View My C.V.

Education

  • MD, Medicine, Duke University School Of Medicine, 1979

Research Interests

  • Breast Cancer - Surgical Treatment
  • Melanoma - Surgical Treatment
  • Lymphatic Mapping and Sentinel Lymph Node Biopsy

Recent Publications

  • Egger ME, Bower MR, Czyszczon IA, Farghaly H, Noyes RD, Reintgen DS, Martin RC, Scoggins CR, Stromberg AJ, McMasters KM. Comparison of sentinel lymph node micrometastatic tumor burden measurements in melanoma. Journal of the American College of Surgeons. 218(4) : 519-28, 2014. http://www.ncbi.nlm.nih.gov/pubmed/24491245
  • Matz D, Kerivan L, Reintgen M, Akman K, Lozicki A, Causey T, Clynes C, Giuliano R, Acs G, Cox J, Cox C, Reintgen D. Breast preservation in women with giant juvenile fibroadenoma. Clinical breast cancer. 13(3) : 219-22, 2013. http://www.ncbi.nlm.nih.gov/pubmed/23245878
  • Reintgen M, Murray L, Akman K, Giuliano R, Lozicki A, Shivers S, Reintgen D. Evidence for a better nodal staging system for melanoma: the clinical relevance of metastatic disease confined to the sentinel lymph nodes. Annals of surgical oncology. 20(2) : 668-74, 2013. http://www.ncbi.nlm.nih.gov/pubmed/23054112
  • Egger ME, Callender GG, McMasters KM, Ross MI, Martin RC, Edwards MJ, Urist MM, Noyes RD, Sussman JJ, Reintgen DS, Stromberg AJ, Scoggins CR. Diversity of stage III melanoma in the era of sentinel lymph node biopsy. Annals of surgical oncology. 20(3) : 956-63, 2013. http://www.ncbi.nlm.nih.gov/pubmed/23064795
  • Howard JH, Thompson JF, Mozzillo N, Nieweg OE, Hoekstra HJ, Roses DF, Sondak VK, Reintgen DS, Kashani-Sabet M, Karakousis CP, Coventry BJ, Kraybill WG, Smithers BM, Elashoff R, Stern SL, Cochran AJ, Faries MB, Morton DL. Metastasectomy for distant metastatic melanoma: analysis of data from the first Multicenter Selective Lymphadenectomy Trial (MSLT-I). Annals of surgical oncology. 19(8) : 2547-55, 2012. http://www.ncbi.nlm.nih.gov/pubmed/22648554
  • Murray L, Reintgen M, Akman K, Cox C, Cox J, Reintgen D, Greenberg H, Vrcel V. Pleomorphic lobular carcinoma in situ: treatment options for a new pathologic entity. Clinical breast cancer. 12(1) : 76-9, 2012. http://www.ncbi.nlm.nih.gov/pubmed/22037287